+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Itraconazole"

Onychomycosis - Pipeline Insight, 2024 - Product Thumbnail Image

Onychomycosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2024 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Otomycosis - Pipeline Insight, 2024 - Product Thumbnail Image

Otomycosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Onychomycosis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Onychomycosis Market Report and Forecast 2024-2032

  • Report
  • October 2023
  • 160 Pages
  • Global
From
From
From
From
From
Anti-Infectious Disease Drugs Markets in China - Product Thumbnail Image

Anti-Infectious Disease Drugs Markets in China

  • Report
  • August 2024
  • 229 Pages
  • China
From
From
Loading Indicator

Itraconazole is an antifungal medication used to treat a variety of fungal infections, including those caused by Aspergillus, Blastomyces, Coccidioides, Histoplasma, and Candida species. It is commonly used to treat infections of the skin, nails, and lungs, as well as systemic fungal infections. Itraconazole is available in both oral and intravenous formulations. Itraconazole is a key component of the infectious diseases drugs market, as it is used to treat a wide range of fungal infections. It is often used in combination with other antifungal medications, such as fluconazole and amphotericin B, to provide a more comprehensive treatment. Itraconazole is also used to prevent fungal infections in patients who are immunocompromised or have a weakened immune system. The Itraconazole market is highly competitive, with a number of major pharmaceutical companies offering their own formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more